Neocoast

Neocoast company information, Employees & Contact Information

Explore related pages

Related company profiles:

At Neocoast, we’re passionate about unlocking the full potential of your ideas and turning them into reality with custom software solutions designed specifically for your unique needs. We’re here to support your success every step of the way: • Scale your team 📈 • Build from the ground up 🏗️ • Discover new ways to grow your product 🌱 Our expert team collaborates closely with you to bring your vision to life—creating innovative, functional, and user-friendly products. We specialize in sectors such as Health, E-commerce, Education, Finance, and more, ensuring that our solutions address the specific challenges and requirements of your industry. We believe in building strong, lasting partnerships through transparent communication, always striving to make your journey seamless and successful. The solution you've been searching for is here at Neocoast—we're ready for your next challenge! 💡

Company Details

Employees
57
Founded
-
Address
Joaquín De Salterain, 1081,uruguay
Phone
+598 543 5432
Email
he****@****ast.com
Industry
It Services And It Consulting
NAICS
Computer Systems Design and Related Services
Other Computer Related Services
HQ
Montevideo, Montevideo
Looking for a particular Neocoast employee's phone or email?

Neocoast Questions

News

Perioperative durvalumab plus chemotherapy plus new agents for resectable non-small-cell lung cancer: the platform phase 2 NeoCOAST-2 trial - Nature

Perioperative durvalumab plus chemotherapy plus new agents for resectable non-small-cell lung cancer: the platform phase 2 NeoCOAST-2 trial Nature

AstraZeneca’s NeoCOAST-2 Study: A New Frontier in Lung Cancer Treatment - TipRanks

AstraZeneca’s NeoCOAST-2 Study: A New Frontier in Lung Cancer Treatment TipRanks

AstraZeneca’s NeoCOAST-2 Study: A New Horizon in Lung Cancer Treatment - TipRanks

AstraZeneca’s NeoCOAST-2 Study: A New Horizon in Lung Cancer Treatment TipRanks

NeoCOAST 2 Trial Durvalumab Plus Novel Agents May Increase Pathologic Responses in Resectable NSCLC - The ASCO Post

NeoCOAST 2 Trial Durvalumab Plus Novel Agents May Increase Pathologic Responses in Resectable NSCLC The ASCO Post

Pre-surgical combination therapy shows promising results for NSCLC - MD Anderson Cancer Center

Pre-surgical combination therapy shows promising results for NSCLC MD Anderson Cancer Center

Novel Perioperative Combinations Show Efficacy in Resectable NSCLC - OncLive

Novel Perioperative Combinations Show Efficacy in Resectable NSCLC OncLive

Drug Combo Demonstrates Efficacy, Safety in Resectable NSCLC: NeoCOAST-2 Data From WCLC 2024 - Oncology News Central

Drug Combo Demonstrates Efficacy, Safety in Resectable NSCLC: NeoCOAST-2 Data From WCLC 2024 Oncology News Central

Novel Combinations Show Promise in Resectable NSCLC, Led by ADC-Chemo-Immuno Triplet - Targeted Oncology

Novel Combinations Show Promise in Resectable NSCLC, Led by ADC-Chemo-Immuno Triplet Targeted Oncology

Non-Small Cell Lung Cancer Trial Underway for Novel Immunotherapy Treatment - Cleveland Clinic

Non-Small Cell Lung Cancer Trial Underway for Novel Immunotherapy Treatment Cleveland Clinic

DATROWAY® Continues to Show Promising Tumor Responses as Part of Combination Regimens in Patients with Early and Advanced Non-Small Cell Lung Cancer - BioSpace

DATROWAY® Continues to Show Promising Tumor Responses as Part of Combination Regimens in Patients with Early and Advanced Non-Small Cell Lung Cancer BioSpace

Combination immunotherapy treatment effective before lung cancer surgery - MD Anderson Cancer Center

Combination immunotherapy treatment effective before lung cancer surgery MD Anderson Cancer Center

Top Neocoast Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant